Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Fusion proteins and antibodies targeting human red blood cell antigens

Fusion proteins and antibodies targeting human red blood cell antigens

US Patent 11629198 · Granted Apr 18, 2023

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Compositions and methods for retrieving tumor-related antibodies and antigens2025
Humanized anti-GDNF family alpha-receptor 4 (GRF-alpha-4) antibodies and chimeri2025
Canine monoclonal antibodies against canine cytotoxic T lymphocyte associated pr2024
Treatment of cancer using GFR alpha-4 chimeric antigen receptor2024
Humanized anti-GDNF family alpha-receptor 4 (GRF-alpha-4) antibodies and chimeri2023
Human monoclonal autoantibodies to ADAMTS13 and uses thereof2023
Methods and compositions for drug delivery2021
Anti-TEM1 antibodies and uses thereof2021
Targeted self-assembly of functionalized carbon nanotubes on tumors2021
Treatment of cancer using GFR α-4 chimeric antigen receptor2020
Anti-TEM1 antibodies and uses thereof2018
Targeted self-assembly of functionalized carbon nanotubes on tumors2018